Literature DB >> 7020507

Bronchoalveolar cells in advanced pulmonary sarcoidosis.

C Roth, G J Huchon, A Arnoux, G Stanislas-Leguern, J H Marsac, J Chretien.   

Abstract

We performed bronchoalveolar lavage (BAL) in 120 subjects: 94 patients with sarcoidosis, 11 patients with idiopathic pulmonary fibrosis (IPF), and 15 normal volunteers. By counting cells and comparing the results with those from control subjects, we found a high percentage of lymphocytes in BAL fluid from all patients with sarcoidosis and a high percentage of neutrophils (NE) in BAL fluid from patients with IPF. In addition, we observed a significantly higher proportion of NE in the 14 patients with advanced sarcoidosis (i.e., fibrosis and bullous radiological patterns), than was seen in the 80 patients with early stages of involvement (i.e., bilateral hilar lymphadenopathy and/or pulmonary infiltrations) (p less than 0.001). The NE count exceeded the normal value of 3.5% in 9 of the 14 patients with advanced sarcoidosis but only in 1 of the 80 patients with early disease (p less than 0.001). We believe that advanced sarcoidosis is one of the conditions in which a simultaneous increase in both NE and lymphocytes in BAL fluid can be observed. The NE count in bronchoalveolar fluid in patients with sarcoidosis, as in patients with IPF, may indicate evolution of the granulomatous process toward pulmonary fibrosis. These phenomena point out the potential practical value of iterative BAL in patients with sarcoidosis in assessing the prognosis of their disease.

Entities:  

Mesh:

Year:  1981        PMID: 7020507     DOI: 10.1164/arrd.1981.124.1.9

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  9 in total

1.  In vitro synthesis of angiotensin-converting enzyme by alveolar macrophages is increased in disseminated sarcoidosis.

Authors:  G Stanislas-Leguern; M Mordelet-Dambrine; D Dusser; M Huesca; J Chretien; G J Huchon
Journal:  Lung       Date:  1986       Impact factor: 2.584

Review 2.  Characteristics and clinical significance of the lymphocytic alveolitis in interstitial lung disorders.

Authors:  G A Rossi; B Balbi; S Lantero; C Ravazzoni
Journal:  Lung       Date:  1990       Impact factor: 2.584

3.  Bronchoalveolar lavage.

Authors:  J Golden
Journal:  West J Med       Date:  1986-09

4.  New and old concepts in sarcoidosis.

Authors: 
Journal:  West J Med       Date:  1983-04

Review 5.  Alveolitis: the key to the interstitial lung disorders.

Authors:  B A Keogh; R G Crystal
Journal:  Thorax       Date:  1982-01       Impact factor: 9.139

6.  Collagenase and fibronectin in bronchoalveolar lavage fluid in patients with sarcoidosis.

Authors:  C O'Connor; C Odlum; A Van Breda; C Power; M X Fitzgerald
Journal:  Thorax       Date:  1988-05       Impact factor: 9.139

7.  Chronic pulmonary sarcoidosis: relationship between lung lavage cell counts, chest radiograph, and results of standard lung function tests.

Authors:  Y H Lin; P L Haslam; M Turner-Warwick
Journal:  Thorax       Date:  1985-07       Impact factor: 9.139

8.  Comparison of lymphocyte immune phenotypes in bronchoalveolar lavage of non-smoking patients with sarcoidosis and other interstitial lung diseases.

Authors:  Eva Novosadova; Zdenka Navratilova; Marta Ordeltova; Monika Zurkova; Jaromir Zatloukal; Vitezslav Kolek; Martin Petrek
Journal:  J Thorac Dis       Date:  2019-06       Impact factor: 2.895

Review 9.  Use of bronchoalveolar lavage to detect lung damage.

Authors:  R F Henderson
Journal:  Environ Health Perspect       Date:  1984-06       Impact factor: 9.031

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.